Back to mobile site

Cantor Fitzgerald Reiterates Fortress Biotech (FBIO) at Overweight, $6 PT, "Upward Earnings Estimate Revisions and Multiple Expansion will Drive FBIO's Stock Higher"

April 6, 2022 6:13 AM EDT Send to a Friend
Cantor Fitzgerald analyst Jennifer Kim reiterated an Overweight rating and $6.00 price target on Fortress Biotech (NASDAQ: FBIO)The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login